Gut microbiota in autism and mood disordersGuidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015Correlates of HCV seropositivity among familial contacts of HCV positive patientsSocio-demographic determinants of coinfections by HIV, hepatitis B and hepatitis C viruses in central Italian prisonersLactobacillus acidophilus protects tight junctions from aspirin damage in HT-29 cellsProphylactic aspirin therapy does not increase faecal calprotectin concentrationsAcute hepatitis caused by a natural lipid-lowering product: when "alternative" medicine is no "alternative" at allWorsening of gastroesophageal reflux symptoms in professional singers during performances.Reflux symptoms in professional opera choristers.Coeliac disease and hearing loss: preliminary data on a new possible association.HCV infection and extrahepatic manifestations.[Helicobacter pylori infection: from gastric to systemic disease].Effect of different probiotic preparations on anti-helicobacter pylori therapy-related side effects: a parallel group, triple blind, placebo-controlled study.Percutaneous laser ablation of hepatocellular carcinoma in patients with liver cirrhosis awaiting liver transplantation.Association between hypothyroidism and small intestinal bacterial overgrowth.Small intestinal bacterial overgrowth: diagnosis and treatment.Evaluation of thermal water in patients with functional dyspepsia and irritable bowel syndrome accompanying constipation.High prevalence of celiac disease in patients with lactose intolerance.Baclofen in the treatment of alcohol withdrawal syndrome: a comparative study vs diazepam.Biofilm demolition and antibiotic treatment to eradicate resistant Helicobacter pylori: a clinical trial.Metadoxine in acute alcohol intoxication: a double-blind, randomized, placebo-controlled study.Regional cerebral hypoperfusion in patients with celiac disease.Origin of celiac disease: how old are predisposing haplotypes?Extraintestinal manifestations in inflammatory bowel disease.Management and treatment of lactose malabsorption.Eradication of small intestinal bacterial overgrowth and oro-cecal transit in diabetics.Rapid regression of psoriasis in a coeliac patient after gluten-free diet. A case report and review of the literature.Recurrent acute hepatitis associated with use of cetirizine.Levofloxacin-based triple therapy in first-line treatment for Helicobacter pylori eradication.Psychosocial findings in alcohol-dependent patients before and after three months of total alcohol abstinence.Role of probiotics in patients with Helicobacter pylori infection.Effectiveness and safety of baclofen for maintenance of alcohol abstinence in alcohol-dependent patients with liver cirrhosis: randomised, double-blind controlled study.Adverse reactions to food: allergies and intolerances.Food allergy and food intolerance: diagnosis and treatment.Autoimmune enteropathy in children and adults.Review article: inherited thrombophilia in inflammatory bowel disease.Celiac disease and myointimal proliferation: a possible correlation?Helicobacter pylori and extragastric diseases -- other helicobacters.Systemic inflammatory diseases and silicone breast prostheses: report of a case of adult still disease and review of the literature.Comparison of 1 and 2 weeks of omeprazole, amoxicillin and clarithromycin treatment for Helicobacter pylori eradication: the HYPER Study.
P50
Q26772308-90CFEA5B-327B-43E7-B293-0647C47F8E27Q26801010-4EDBEB98-457D-46EF-A1C0-CEB6E420FA1BQ27477498-3FA81EF9-B7CA-4200-92EA-3CFBB6709DD7Q27481330-18E66D03-5560-49F1-8DAB-3D6B7E6AA1C1Q28169032-091A3085-F6FD-4486-925E-8E303F3A2250Q28200066-3270B284-D80E-4820-97A0-23600E039A96Q28242961-59EA7A32-6748-4D94-96E2-D952B90A638CQ30540329-24825B07-42F3-4199-BC81-B92BBD76D0CCQ30542438-541E7697-FF27-4508-AE28-E747633DA5D5Q31127853-D50198F9-81F0-40B4-BB17-6DC7AEACF002Q33348842-E8828869-11F3-4F98-80AF-7FB370E450FBQ33389141-96B6011A-FAF3-4116-ADAF-8F9FC0891492Q33426019-441CB00F-64EE-41C6-8A69-C7BEE5C0B545Q33426681-7B4EAE61-4C64-4A9A-800F-D4E2F87B6032Q33437823-F8C6A852-00EB-40DE-AFC0-F70D194FB270Q33438120-51181CF5-B727-4431-851A-51B572FF3D16Q33868502-A0903609-4F19-4239-8E25-664D79026947Q33985857-7FCB1B34-FCD3-4007-BDF4-2EF030650B2DQ33993651-DEABA0D2-74F8-4315-AE9A-0B2F2C933BEBQ34115887-A1E1CA24-7DA4-4287-A1CE-3F2960F2045FQ34121261-7EF44E58-B5F5-4E69-BC31-145F345B67EBQ34301131-8B5CC138-C761-4BE2-A304-8FC98D510BB2Q34445513-951C9E6F-CCB1-4F25-94F4-73BC0F890AA5Q34488386-34ED1854-2D75-4DA1-BEA5-44D9C78B38F3Q34495172-4529E6AB-0FFF-4FC4-97A9-2A8CFE256387Q34528369-729DB0D1-3F0A-4595-8D13-ECE928F6CD47Q34536681-F48813E7-1665-4BDA-832C-742E66D5F7BDQ34551111-8CAE1A4E-2054-4B0A-993A-A32ECADEA60CQ34570815-95924070-46E8-41E9-888A-CB6AADB88715Q34689478-4CCDB25F-E864-43A2-BA6F-992B0E5E3B4CQ34711908-49BC9CC5-F5B9-4EC3-BEDE-ACCEEA136E14Q34722965-4B1C249C-544C-46D4-915B-BEF103D6A468Q34773134-371F71A0-3624-4136-A3C3-F177940F48DDQ34809915-B2143629-7BAB-4CE9-A0DB-CDD722BE296DQ34955595-BA77481C-40F7-472C-A5E4-4A319C9B0E8AQ35158989-EF238079-E8FA-4046-95A8-305F19E6213EQ35195878-E10F2793-31DB-4819-9F0C-C2D29602496CQ35583594-D424026A-CEF4-4E15-883E-32AD2F39224BQ35652739-F1AE3DC4-A52A-4ADA-967F-8E9219014E88Q35761431-D63B4E38-6B72-4F9B-9CC1-84D2DA298743
P50
description
dokter
@id
name
Giovanni Gasbarrini
@ast
Giovanni Gasbarrini
@en
Giovanni Gasbarrini
@es
Giovanni Gasbarrini
@nl
type
label
Giovanni Gasbarrini
@ast
Giovanni Gasbarrini
@en
Giovanni Gasbarrini
@es
Giovanni Gasbarrini
@nl
prefLabel
Giovanni Gasbarrini
@ast
Giovanni Gasbarrini
@en
Giovanni Gasbarrini
@es
Giovanni Gasbarrini
@nl
P214
P106
P21
P214
P31
P396
IT\ICCU\CFIV\024404
P569
1936-08-30T00:00:00Z